• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    More On PBMD

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Prima Biomed Ltd. (PBMD)

    -NasdaqGM
    1.19 Down 0.11(8.34%) Jul 6, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.30
    Open:1.26
    Bid:1.16 x 2000
    Ask:1.26 x 1000
    1y Target Est:N/A
    Beta:1.91
    Next Earnings Date:N/A
    Day's Range:1.15 - 1.30
    52wk Range:0.42 - 6.48
    Volume:1,452,564
    Avg Vol (3m):4,163,220
    Market Cap:54.60M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PBMD

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):53.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Prima BioMed Ltd. researches, develops, and commercializes medical biotechnology products in Australia. The company develops immunocellular therapeutic products for the treatment of cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback